Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Anandia Labs

Request full access

A Canadian independent cannabis analytics, testing and genetics company

Vancouver, CanadaFounded 2013Biotech & Life Sciences

About Anandia Labs

Anandia Labs operates as a specialized biotechnology firm focused on cannabis science, providing analytical testing and genetics services to the regulated Canadian cannabis market. The company was co-founded in November 2013 by Dr. Jonathan Page, a botanist renowned for being the first to sequence the cannabis genome, and chemist John Coleman. Dr. Page's extensive background includes a PhD in botany, postdoctoral research in Germany on cannabis and opium, and work at the National Research Council's Plant Biotechnology Institute, where he made key discoveries in cannabinoid biochemistry. This deep scientific foundation was pivotal in establishing Anandia.

The company's business model is centered on providing a comprehensive suite of fee-based scientific services. Clients, primarily Health Canada Licensed Producers and patient-growers, utilize Anandia for quality control and product development. Services include analytical testing for potency, pesticides, microbes, and terpenes, as well as more advanced offerings like plant genotyping, tissue culture archiving, and cultivar certification. This positions Anandia as a critical third-party testing entity ensuring product safety and credibility for both medical and adult-use cannabis markets. Revenue is generated by delivering these testing services and by leveraging its intellectual property in cannabis genetics for breeding and product development.

A significant milestone in the company's history was its acquisition by Aurora Cannabis in August 2018 for approximately $115 million. This event integrated Anandia into Aurora's vertical strategy, aiming to enhance plant-based innovations, improve cultivation yields, and develop a portfolio of high-value products. Despite the acquisition, Anandia was to continue operating its testing services independently to serve the broader cannabis community and maintain data confidentiality for all its clients. Following the acquisition, Dr. Page assumed the role of Chief Science Officer at Aurora, overseeing a global research operation.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
5
Open positions
None listed
Dealroom signal
54.4/100
Industry
Health, Food
Sub-industry
Pharmaceutical
Sector
Testing, Biotechnology, DNA, Genetics and genomics, Pesticides, Cannabis, Spinout, Genome Engineering, Biotech and Pharma, medical testing
Client focus
B2B

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Jun 2018 $115M $115M Aurora Cannabis —
EARLY VC✓Equity / VC Jan 2018 $11M $43M Green Acre Capital —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Anandia Labs website traffic

Latest recorded traffic for Anandia Labs is 380 monthly website visits, up 46.2% over the last three months. Anandia Labs's team grew 0% over the past year.

Latest monthly visits380 3-month web change+46.2% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Anandia Labs in the Vancouver ecosystem

Live from Dealroom

The Anandia Labs office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Innovation UBC

Series A1 investor entered at this stage

  • Green Acre Capital

Other known investors7 additional known investors

  • Aurora Cannabis
  • Genome British Columbia
  • Origin House
  • The University of British Columbia
  • Agribusiness Advisors
  • ArcView Group
  • York Plains Investment
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇦 Canada100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Anandia Labs on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Anandia Labs’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.